The profile is currenly unclaimed by the seller. All information is provided by CB Insights.

surfacelogix.com

Founded Year

1999

Stage

Acquired | Acquired

Total Raised

$114M

About Surface Logix

Surface Logix with background in biophysical chemistry is developing to create new small molecule drugs.

Surface Logix Headquarter Location

50 Soldiers Field Place

Brighton, Massachusetts, 02135,

United States

617-746-8500

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Surface Logix Patents

Surface Logix has filed 9 patents.

The 3 most popular patent topics include:

  • Abandoned drugs
  • Drug discovery
  • Experimental cancer drugs
patents chart

Application Date

Grant Date

Title

Related Topics

Status

7/19/2018

2/25/2020

Transcription factors, Proteins, Human proteins, Clusters of differentiation, G protein coupled receptors

Grant

Application Date

7/19/2018

Grant Date

2/25/2020

Title

Related Topics

Transcription factors, Proteins, Human proteins, Clusters of differentiation, G protein coupled receptors

Status

Grant

Latest Surface Logix News

Surface Logix reports phase 2A on SLX-4090

Feb 13, 2019

%PDF-1.5 %âăĎÓ12 0 obj > endobjxref12 210000000016 00000 n0000000913 00000 n0000000716 00000 n0000000990 00000 n0000001111 00000 n0000001289 00000 n0000001410 00000 n0000001860 00000 n0000002392 00000 n0000002426 00000 n0000002653 00000 n0000002874 00000 n0000002950 00000 n0000004000 00000 n0000004988 00000 n0000006021 00000 n0000007038 00000 n0000008088 00000 n0000009062 00000 n0000010120 00000 n0000011073 00000 ntrailer]>>startxref0%%EOF14 0 obj>streamxÚb```a``–‘—ř€(ĆĚ00T€„X-•ů€Œ†Đ0HÁu7ba°ˆkÁÖÂňť™˙°^üÜśř‡ŐË*oöóŮ܁43Ј@€ ô¤endstream endobj 13 0 obj> endobj 15 0 obj>/Font>>>/DA(/Helv 0 Tf 0 g )>> endobj 16 0 obj> endobj 17 0 obj>/Font>/ProcSet[/PDF/Text]/ExtGState>>> endobj 18 0 obj> endobj 19 0 obj> endobj 20 0 obj[/ICCBased 32 0 R] endobj 21 0 obj> endobj 22 0 obj> endobj 23 0 obj> endobj 24 0 obj>streamH‰„TێŰ6}÷WĚ#UŹę.=z7녻›ĆĘčćA+Ńś YrE9ç3úĐďíp†ś×)Đڀ8œáÎĺ˙œřĐŔDz2ČńYä{yqyiŽŮFjňşÉ›™N ŇŕÓ_W¨yˇňaŁ/ţҋĽŁŔĹ=ůý|úś˜ź)Š1Šő$őň $ţIđÓĚËH“ÜË2Bą;ß*˝D†|ÖčvźUIá^&ˆŐÇżNgsX>ž[|éěn1˙4_9nŚ^"oďçłbpž÷“ #ÎÂQ‹ˇ˜@—#Füź(î`ľüâFN"¤ăú^,r‰2,Ŕ1¨ď9SĆtO xŇüŕœĄÓ”ĄgËĹĂb6]Bńa_r—TJÜŔ‹ó,>! ć !łÁÝ>ŽŠÇ‡řÍq#Œ¤t/Z{đ$XsOš˛;”Jž8šŽk"ȚłîćJ)Y)3Ú=96.áĆů‰—YvŠ\xIϡ˝€żŃ7°:ë’㊾˞ÖMóFëňČ-ťŽý×Š]j[ŕÓÝ?řUydĆě)řžSŃÍčd¸mĚ6ß2SZ'ĆÍčHüjhh×Ů"[ňW0ëIŘím5ixżľŐ6…)ŤH@Pră^á5UÉZ6”l°Ú~ÍžŤĺwC6ÓC4ŰtźRŠ_(ß蒯oó­Ń?›€t‹.Ážt ›ÔŽ!-^,‰ćž'ąĺ3Zś6VöŁô¨+CّŠŚŘŞoŠOhĐ$e`°ĚŠ…g6÷=ŤG'Çe`kš{rŻŘŞŤz„ŃĽ˙9×c0-ŠEW÷´îLŐsńCŃŽžš„ţđLkŤ\+đšŽÍ7°oi_Vęšw+ĆęFSŁnMSaAÍƆÚ捔ĐăáľőČýŒ‘.ŻűŇp3bƒácŽ|źĘ/ťô;äü^đpȄ…AČą•xKTuېyĎŢỒ`Ι¸sąëiéô8”ŁŞ9ňq[2(ž‰H˙?§žš›Zîâ UyĐŞśrKŻPCß΄óX˜}{zĄšl:^ןTüŒtăé%°ńü˙K0đ|ևjäŃë;ÍIžFkßë‘ç{ŕÁîj;¤? íĆí‘Ăľ™ ş –oIˇtÜCuĐL=C­zý`đc¤ŒšDŁek˙Rjxa‡ÖÚŽČđďÂŔÔ Ĺ–$eg×g"œŔ\[óásاÝ^đţ` Hƒěđendstream endobj 25 0 obj>streamH‰|UÍnœ0žç)ćU@ŔÂf97§Ş‡HAÍĄęÁłXLąˇ›}Žô;?&Q5lg曟ĎCóĺ*ŻŇ}‘As{•di–öМŻžG'7é>ŇOj2ń>š5řAƒSńĽ˝ö—ë áă~mœäѨůvUd2҇ő~4_Ž’ *ÉӜV$ź] M+ĐY-ĐzŠ˘A­“jíO3óQÇdyWiľ‹çbŽłď5Z/;Ë:ŠÁ"Kâ|“ˇ>ÎđʌŹĄˆę,€Á@Q~\Ď~ƒďDi2ł\9ŻWÝńŹz‘”—4Ÿ$ăę%ă\śRśx—‘%îÎ:Ĺö\]¸˙Ę*OIÉkVgź‚ćĄî”T‰˝V-bđ¤4ĄˇŽĎœ7ˆ‚ßG°+H”sÔjč¤ÍXşf=*ĺ,-IiSš¸šˇZ˛Ě¤Ă‡ĂÖá2Í7ë3 g2ŒwZԌ"™-’ű¸FĄž;˛ úoľŒÜĹ.źŮŔÝŔŤrŠGqNôO݅ŠK[*.Ý?a^ÔĚűpŔ,IF…f[#!BwqŁŕ/ŸžĚVÜ÷1ž)̇ԧDŽÔÇÇ&Ą—p+p6°ë×I¸ľ"ăă{(X†˜×4N¸˙z‘VőĄzAGĂçAw„~7HwAćQŕQĄľVŁˆŕĄÍYˆ¤ťzĘLŰłBĎŞűKlę{âcŤZ#O$Ä76wA_ĚW"łĽ…­Vĺ%˛xD1/ߗšS,(Yfc†Œ˘ęTXqŽŞÁŔC†‡ĘvľĂä1Ň1ŽEďŽ@Cƒ/§ˇĎŕœoE†=*°„Š(ËŐCœTxđÖłhšVüţ„†”Čnju€>ŇRn pż íJĆu řF‡"¤ÜjöwAQ‡,LZĎo˛§§ ›Ď€Í'1ž$ŠCHą Ą(š"ez˝qŻo>oţI,ĂÄ~둏v™pš"YŠAŇš?­=ŃŻ \JîŕŤĺőhžRx~Â3Î[Ů-ř;mOâ\ Ö:†śˆXăLؘjÁiążĆęí#łXÂŁ@úá%šďüţvüżĂĹńßiGý˘#Îü#Ÿ ąrzv×ažŻvq0[žö`Ĺn-¸Ĺ:żđvU™Ň:ŤsůA˙gh̝%0Ŕ÷ɛŁLńŇę éđ'đ(ƒĂCPwöŸ^/ż6'#ČĚGLţ0 MTîGendstream endobj 26 0 obj>streamH‰lUKŤ6ŢçWœ]M5 `ݑŞ^ÔJ7Ň]T]8`‚o FؙL~Gďîy0“dڕ}>ďóy˙eguҤMq–dy–Ăţy“&iş­`ßnbşó˛ůS˝Dť¤VĎję%nŚÝhřôQźM˘ áËZ-nDYŽ`Őy•cô`™?‰|gę,”Źćóꣿö_6Ů. )wuéGŒĹGŒi#1&đŰivřŞTKĐESŞńúQ•ěÔזźaڍŁm’Š‚yi“ňů“Í—•0ŕĹ&Áźš‰o8šř=œĎ…ËoAUԌďśj‰rŹëmT&•ŠŒ2,‚‹Ś’ęäôÁN,;žWƠ̍$Ó/îaĐĚQŠ:ŕz‘Í#żŃ­9¸k€.žđúÂl˜ˆăž7m'nyd%2L]Ý˙ĚyĺÍ-ŻBňęŁZ§6P€`CÁřŕŸŕ‚ăĄl;€H=g­›źő˝Ť)Ŕ…Eč0Çö‡á˝ËMš•ˇ.ߚŒ\ö‹Yt•‘šÓĚ7wžřěŕ "+ômW[ŽŠc† ˜ąćëa\­Xî+cIĆEńÖfŽçs›˙;{3›áĆbé™ŔĽ(ĐůIŻ¨1ž&ě3ěiÖŘ÷AFń˜rB]ľKÇú2Ľ˛!ů!Ś€Ő+›şüŸÍ­k‰ělţĹ,ôč̲”F{ÓAŔ@b˛ě,çJśăÊŃʎËVŽbě*đ˘xœäě×wň;.Ć/Ŕ˝éă`t‚$~U{ áÍŹ˘…DĂLÁ?XDě>*ôŘť|wë]&ZĎ>&X*šÚWÓÉś jĐůF˛Çx‹A‚:ŸČuĄ~°Ńƒx]'V:x^iÝ7;ŽVŸŕ ĄŚZłŽĹ/ƒ5=a:ČEÇż÷˝˝‹háőž[Éíö–ÇÚéŻçĽ§b”J^âćř˛o —Ť¤Áš•‚ž˘Ę—Xżu˜p™TaŘi=؆Çёˇ´|éäl#!xĄ;8ĎbB˙m@ő‘ô”cą×xmÍb;žń@˘sžő. [{Ç3—­3—ÉĚe2s͜wgž.÷[Ő&¨–­YŐѸ4j‘‡ĄxÉŹZăěVyHŕWšâ— Tˇ÷ňFf'D´žW°ňŁ •“œß„s äănViq?Ł_łŚ{dx˘d*ĺ.+va0‚jcůŠśLˆÄf]Žƒ ›ŕÜ(/qćpŔßbÁŢ:Ióźě… (ôZendstream endobj 27 0 obj>streamH‰dUɎă6˝÷Wԑ,AűrŸS0ŒoÓ9Č2m-‹Eť[żäƒSeuϜD˛öŞWOIœ$yűţ%J𘌰ůŠ]ĹľJÚä_?XZ­ňfâŤ×)VéD4‚ŽăJy}wgĽYG…2|„w#ĘgQž/QJG+F3čöžDi'YVC„‘˛4ƒýˇĘ3Ϟ)'ľ¤ě(FŽnÎĚfňşÁó,>;˜‡3'~r5œXěMŒ­ówyHKeÍk ĹΊJ˝×‰ľš‹ťĄ‡A—XFˆç%5÷0!žHíSéúOŠM Ęâ˛mĘľĘ4§*ů”I‘?žDŽýG9ZΚüC“}˜q§Ł†ÚĚyY׍;qœŚq•T)$Ťă¤y:ݛěÍËěÍu ZsŐëýwă(ׅŻĐ=$ă.hÝa4Ď mŢ[t›Q•K”aşpâ­:Ţ:ň…éÚčˆRžaďělŻÝ(ˇ€„,Ë˘,CBą!Ą•(4łR98Ď#öşĹüs`Oƒ@Ńp”xÇ(Ő|"ś‚›ł^4IÖUí˙~Őŕ/Rs'U“m5çĺ3›Ś’l­ŠUv˝ŸĂńŔ2FŠŁĆąőo¸#j:c'뎝§;Ë6'ö'+’řÔŮe‰c}\ĎT9öÔK8fču†ˇÉžSL\çĂ¨żHŽœŰuŔŃL_”8Yr#ę¸z†ĺN„ë›–ĄA?ą¸Ĺ›všáŠ…ň›LÉĺ ą€3G!’^¸c:—ŹVpżyöÓ˝Â˙Ę$„Ş'…Pż §Řŕš.×-­Š&ÔpČý˘‹8#ŕÔ$"ŕԟ˜e:ň°Kôľbcp\8Sƒ„ Ú|ű$ŔwËőĆŚ—N˘#wHßĹÎő÷ąc"ŰZ –/4*ţá·10łX!fĚçôwXRťş˙ƒ[­,”Ň€Ŕ =ôöNťÄŚ#Q5ĄŻß˛édŽükAćĂ8ƒ—Š×q›´Ÿř&Űţ0+,g0'Ü9âAd‰ĺŐĚÓ¸Ŕ0ń;ůR3 8óNbý œÔę;?Č8ŇWđ˛ŁX‡é‡\~Ľ|˨پPœ>r8ňmHJÜŤé/˘Äźž)˘ńfŐ!Bęą1Źů! :˝|ź|Ěr~h:¤l`äçŕäaÂ/ćU˝ăOĆ° ­Öůž8G˘_ď3{ó{)§Îűĺňv[‡‚˙0 óŒendstream endobj 28 0 obj>streamH‰\Ënă6𞯘#YŹ=,K>.°§E¨oé$Šś…U(ƒ¤’č7Z ßŰyĐv6ćý>ŤYďóšřűŞł:o•Ő­ňşÎ÷ęo şEŘťQ~–xanÂüšwˆ†\üqüĎťÄňě#0ĐY‘7ęŐÂ@ÖŹsƒ_Ö3â—xłCr{ÔG"čÇďOÇߞŠź(ŞÍSFżĹŽoOĎjÔ{’#,Qwęb1aö"k~3›?a2ýĚË6/ť˛ƒŽßŘwÝÜ}—âNśÇxё.Őęí˝f:ŤZ*čĽÇTŃ*R1{âż-ŤašĽ2ËęÄJŒ’mvsŽÁ•UYÝB(8}Ž`/!„éěŚÓdtśĎŠžXťˆŃľtŻŢ'íňJ™‰ľ‰0˜Ĺ%=ë]HDN! ;4‡ýł`¤"Mž˙Ľ"ťö^‘Ş’xfÔŻPżeő‚ţŢĄá/bůí" ,›wބ8‹6Ö°¨^ăhŢţ+ĺ­l˘,gŃ}@Érj¸ŕţVĐ;´ëî=}dPŚ¨]ŰŇ)ťe2p]˜­K¤žń9‡ż~ĎvŒ‡‚!\„@Ě,4Ҥ+Ľěň˘lŞĽ|×!ľÖʼnWŚP3¸%Ââ0{ľÁä8oЁqD&Ń+ŠN#3íĆöAjXŠ,w´'•°$ )PŠčÓÄŐőcá:‰kÂ5ęxvŠWr„5ešA oy›ĂĘ`ŽIřD7(iaĚÂŘ˕ŹĂ÷:ë°ó˙°Y´&‡EźŠŻ™Nýę8.wˇŃËD Ľn¤¤ďą™ý RâÜ_Ł/ˇ›´ÝĎłJÇŐ¤äĎźŐ;äŽb8ö?í#Ëä˙,íiXS˛LI+Ý°ďO)Š—§Ä›!ôL9ٸĽ†_™ŕé&ÔjŽŽP|JZ€0‰Š˛đ"Â+ZĺškŐăBqlŸć…î@Š°­%Âߟ럲sŽŐ˜0ÓG4YŤ„.ŽŞ@Ö@Bsčšű>Ě)ń|ׁĘŘĘ8Öôŕw`ƒ3SŹł}?Ď,żŃő“Č[~ŚRă&Ç´hCLŚ-_­`轚ő2Ăhq—gAI|G+uÁyú˜4_Š˙8úB˝eűiévl’-ďHƒ;"pu#Ăđ!ćßK‰ŞÁ~†-D+:ä‹ fňféŁqÚ˙4Ď >XiI§đ…łFň$Œë\*0ÁBě͜ʇ1B’Ô?ŕ ;€ éendstream endobj 29 0 obj>streamH‰tUËrë6Ýç+°”:ąF’ĺHŢöŢM;é43ńŽÓMS6ďŐÕ('ţŽvÓż-ˆCů‘ÜnL„€ƒƒ‡7ż>l~zH“4]V´Ń/fKÚź=üőńS˛ŽNń2Š"3h\[#Çă?—ÉS4k[Óš¸bÉěč+Ť–Ń/Š$‹ŃҋťŠ‘7z}“Ó׉^ĹšŒÚGúr…55źjÓÎA¨ăŒ!ëxáÁÁň÷xw°śÚpř‚^§ĄVÚPüçćšu~É:-‘őłxî÷6^1˘÷„ţţ…=.ŁŽÜHHŤŃˆoÍăŚß6/ń"Ë°ŘN^v+§ĺGâÄQ¸ô0yźâň>_Óɚ7™Rys‡`´WŁzŘuΈŸŃÓ]D.h•(›űd‹k˛k$ë­¸TKŽ”ŇŽ:ŸŐ*r¤FRČÔo坒Sű@yÔpŽśĎ%ă$×vräë 6° Ľ´ůú=Hý$5ŕíŻ í7†@u? :‹é’”ŐVŽšp6ŔŕhŕÉYĐĎg0ł˜1ř4ň,ż ůL˛?C:ěěA `2“dޏfpH“ťdÎV÷eÜâą?ÎŁŐ#őľTƒĆV!HťEiŒžîX_ŕ/GčpمxĄ„ť{Έ¤´ ‘îű¤ź–!GňžŰÜŸň¸ůŚŠ¸mŹXEÝČ#2@žö9Yc Laf*™Ç Ť˜|.„ˇb߅­šˇe†ámcôĄƒ˛Áą?ÓK—‘ruźć{§ŃĐ>ŠLofn‡ţc;|^a4=Łźëaම7ˇä°*hgFLçžć¤űöŘOؗ)WŘäÔw3Ë|T砐ĆËŁ{h^QĄóJ”|éKŽĎtŘAaű„­‘  p"ůŞúÁTVa^Ÿß…LSşNÉÔ5ŚRă/ŔžÖü™LƒŠlyúW؊źě§/Źhý#ŽĘőľřůľçęˇę'–sýŚďžŃMíśű_ąnOáŢëď Ą>úóÂ>ąŕążýˇ:)$×ŕ-l‹Ü-¸8#şé4ĘźöĽ0;ŹŹí™z˜ń–˘š˙Ól•ßěÄ+ž$˙ِPY…?˜đŠ0™}˜Lż„w~ s3w=7+ČÓXśź´żDża…ţ` ťäřendstream endobj 30 0 obj>streamH‰„U;ă6î÷WLI'EO[žî€Ť‚°ŔŞ;¤ %ĘÖEŠ˛×÷;Ňäßf´˝Ů-R ‡óüf†Ă4IÓbMű§xĚ2h.OߕędŤ\T$…2“‰6Č͝eş.ĐÚi2ŽĎ”!Ú&u˛>(Fčk§üMĚ$ů˘?šßžRˆó¤ÚŐ4_Ÿ(dqžVźAwľ:p†M—•Éč蝝Ŕ™7ŕÝUIĽtgHFfŕäěYî;=ÉÔ*Î '‘m“ź(kHoI䏤Ą.Š+D/ŘZd”E§ˆŽÜ$2Í~˛S`{4Ů* `tz?Œƒż~p.ń-´Îň,ż×eűčJ. )=5"Żš/Ľš4śÁ¸$ĂĆ´Çٲxr¸Â3Ő>WÚSj€îĐ|oÁ°ćŹ÷˘hŕeu˝AČ ř|Ż°´C0wÜç\-žc,wߌŽůEŔT0‚ĽCŁ zążĂ* ‚ĺdh°TeŠ(ćQbáÄ:Gí÷ŸĂü°÷Ź†Đ¸Ţ˛őD§5L ˜`fZt'‹¨ĹEťŢpÁӑNäv¤Ś˘D,ě‰cMX˙\ ?ƒÇĂ –ĺęN°žĐ¸’ęcś†šš˝‚–S'ΌŚĺŠîÔ9*ąÍ89‰(źŹŹŕúhGCßęÝD˙‚ëNŽ/Śc/ߘžĆ%Ót—ĘýEěüÂ!˘^`Y>üĹdŲPř˙i¨yôĐËŮI#ÚŤ71 ÇFiw0rş—nÖҕŐĘ"TŰuƁč[yˇ8v%Ž~ˇßt2ŕé7yŔŕĹ!oÖÎg3‡,$ÙvÔý9†ďžcZ`ĆťŔËuńfhœRzz…˝2úĹôRtĐńĄř˝yŚë*Ŕ˛9˘çvÜ>P›bGŁSĐ>^Ä]"ŠţÚ4%`őűK5,4,/č)W{ťzZ@ᕺĄÓśý|ó¸Ű$+6eXŒœź`Ć͏§8ß/ňŤÁ*WęíůČkC/rŮ1°řľĂĹČ>xL‡•ć”.hNYë˘oÝĎęěÍÖ.ŢüuhçRÓsÇ'; ?M÷IRčěʗ؆xĎ'~ྡྷŁ–ž+1ü$=ˇšŐźĽŸĄÄ‘tv ŸťË†0šô |o˝fɢÝӞ@źd6$~]äχÓĐą gŻ˝ýfť4ŤŢüfőŁ. dËş˙‘\/ţŹ­˜=ӜŐĘđœu„Ÿ~,ććŔY'üHŠăŘÝf’¤ŘLţ×đăËӔ%8đŻ ŤĽendstream endobj 31 0 obj>streamH‰lUM“›8˝űWôQ¤0S5ÉajśvŞÂm&dLȋdĎňďˇ?ŔNm튼Fę~ÝzŻŠŸwarˆŞ8É!L˘$MR¨ŸvqÇűÔÍ.¤%9?vojě 8D…˛'ąß_‚"*Ő?aĆ6Žbś`g¸đj0hŚtcŽźˇ`ŮNĆ-Uc Őěč4ŠZčŞ?łk6lřžżĆáiYŻ§ƒpUNAIą)ćAÍ-É ĺűZR-.âSü¨Ÿwő'.1-ď%Ć{)ńŐ: r;a%xŸ6SŰŁÝ+=°?ËžŁjXłzZ„ůa$‚ŃhwMË{Đ^Ŕfó÷•]fZ]ýÄ{o曰PŢi‰.ą—)š%‚oÚyńMr “đż—ś/Ż—HiôXőDWrő6gŢŰÁ°uA˜)=:(C-Cř–Úœ(řĐN@ŽrTJ–ä%ŁŘŽçkӴڎݠ§Vf[l4ňg#çŻüĽ ˀ™?8Š—ťůŚ(rą]čNTßąď죕 WŢś ֈą¨Ę‚ćęśËô\vâƒ=5 YŢqą”•’fiń]#Ƀ@…t™Č˜‰ř3čöffˇÖgnřޘ7-*j÷!Up9k^ĚŁně/zŮBMĆs ž‘ÔᖛUZ–„ŕM9š8^ž´^í°&Zháŕbć“]Sś­|BFr˜MweéůNHÚŻ„ŒĹçşÎ k>íb@6ćU\Ý[ńčD.ř‚ ru´Wß_dF$4#śřđ´°Ë ýĽG ˘Š1Ľ{-ÄĂÁ_G#§„ˇ˝_6$… I“(ÍĹú(„"Śü(‡úç.Üž2Ú2ßĐţň# ‰ćŞw ň‡ÉŢĚ Ŕ';…nqތ‰,JKŒqçDʜŕșDî=‡JՍĆJŽdƒ AYgG=Đ8ę†E>Đ$jWÂůYOîd‚3Îô9_§ő'|őߥŸ=ŚĆúŠ„Úö4+ź!Mçj’đďęĎúő=¸†Nžű#[–PBâűpÜŽvě€Ĺ0°ÇJŮ)¨¨&é+j´Ź~×ZţŔ&ĐčW!ÂŢŞ5Z´=Ńą3ěƒvq˜X \´+Ůđó;BGOw–}­wđŻ mŘť†endstream endobj 32 0 obj>streamH‰œ–yTSwÇoɞ•°Ăc [€°5la‘QIBHŘADED„Ş•2ÖmtFOE.Žc­Ö}ęŇő0ęč8´×Ž8GNgŚÓďď÷9÷wďďÝß˝÷ó  'ĽŞľŐ0 Ö ĎJŒĹb¤ 2y­.-;!ŕ’ĆK°ZÜ ü‹ž^i˝"LĘŔ0đ˙‰-×é @8(”ľrœ;qŽŞ7čLöœyĽ•&†Qëńqś4ąjž˝ç|ć9ÚčVł)gBŁ0ńiœWו8#Š8wŐŠ•ő8_ĹټʨQăüÜŤQĘj@é&ťA)/ÇŮgş>'K‚ó ČtŐ;\ú” ÓĽ$ŐşF˝ZUnŔÜĺ˜(4TŒ%)뫔ƒ0C&Ż”阤ZŁ“i˜żóœ8ŚÚbx‘ƒEĄÁÁBŃ;…úŻ›żPŚŢÎӓ̹žAüom?çW=€xŻÍúˇśŇ- ŒŻŔňć[›Ëű 0ńžžřÎ}řŚy)7tažžőőő>jĽÜÇTĐ7úŸż@ďźĎÇtܛň`qĘ2™ąĘ€™ę&ŻŽŞ6ęąZLŽÄ„?â_řóyxg)˔zĽČçL­UáíÖ*ÔuľSk˙SeŘO4?׸¸cŻŻŘ°.ň ňˇ ĺŇ R´ ߁Ţô-•’2đ5ßáŢüÜĎ ú÷Sá>ÓŁV­š‹“dĺ`rŁžn~ĎôY &ŕ+`œ;ÂA4ˆÉ 䀰ČA9Đ =¨- t°lĂ`;ťÁ~pŒƒÁ đGp| Ž[`Lƒ‡`Ż "AˆYA+äůCb(Š‡RĄ,¨ *T2B-ШꇆĄĐnč÷ĐQčtş}MA ď —0ÓalťÁž°ŽSŕx Ź‚kŕ&¸^ÁŁđ>ř0|>_ƒ'á‡đ,ÂG! "F$H:Rˆ”!z¤éF‘Qd?r9‹\A&‘GȔˆrQ˘áhš‹ĘŃ´íE‡Ń]čaô4zBgĐ×Á–ŕE#H ‹*B=Ą‹0HŘIřˆp†p0MxJ$ůD1„˜D, V›‰˝Ä­ÄÄăÄKÄťÄY‰dEň"EŇI2’ÔEÚBÚGúŒt™4MzNŚ‘Čţär!YKî ’÷?%_&ß#ż˘°(Ž”0J:EAi¤ôQĆ(Ç()ӔWT6U@ ćP+¨íÔ!ę~ęęmęćDĽeŇÔ´ĺ´!ÚďhŸÓŚh/čş']B/˘éëčҏӿ˘?a0nŒhF!ĂŔXÇŘÍ8Ĺřšń܌kćc&5S˜ľ™˜6ťlö˜Iaş2c˜K™MĚAć!ćEć#…ĺƒ°dŹVÖë(ëk–Íe‹Řél ť—˝‡}Ž}ŸCâ¸qâ9N'çÎ)Î].ÂućJ¸rîî÷wšGä xR^Ż‡÷[ŢoƜchžgŢ`>bţ‰ů$áťńĽü*~˙ ˙:˙Ľ…EŒ…ŇbĹ~‹ËĎ,m,Ł-•–Ý–,ŻYž´ÂŹâ­*­6X[ÝąF­=­3­ë­ˇYŸą~dĂł ˇ‘ŰtŰ´šiŰzÚfŮ6Ű~`{ÁvÖÎŢ.ŃNgˇĹî”Ý#{ž}´}…ý€ý§ö¸‘j‡‡ĎţŠ™c1X6„Ćfm“Ž;'_9 œr:œ8ÝqŚ:‹ËœœO:ϸ8¸¤š´¸ěušéJqť–ťnv=ëúĚMŕ–ďśĘmÜížŔR 4 önť3ÜŁÜkÜGÝŻz=ĕ[=žô„=ƒBş0FX'Ü+œňáű¤útřŒűG”,ę}çďé/÷ńżŔHh8đm W 2p[ŕŸƒ¸AiAŤ‚Ný#8$Xź?řAˆKHIČ{!7Ä aÁa†°ƒa†W†ď żż@°@š`lÁݧYψÉH,˛$ňýČÉ(Ç(YÔhÔ7ŃÎъčŃ÷bűL&Y&9‡Ä%ĆuÇMÄsâsă‡ăżNpJP%ěM˜IJlN§|“ꙪO=–§%§mLť˝ĐuĄváx:H—ŚoLż“!ȨÉřC&13#s$ó/Y˘Ź–ŹłŮÜěâě=ŮOsbsúrnĺşçsOć1óŠňvç=ˏËďϟ\äťh٢óÖę‚#…¤ÂźÂ…ł‹ăoZTÔUt}‰`IÒsK­—V-ý¤˜Y,+>TB(É/ŮSňƒ,]6*›-•–žW:#—Č7Ë*˘ŠĘeżň^YDYŮ}U„jŁęAyTů`ů#ľD=Źţś"Šb{ĹłĘôĘ+ŹĘŻ: !kJ4GľmĽötľ}uCő%—ŽK7YVłŠfFŸ˘ßYŐ.Š=bŕá?SŒîƕƩşČş‘şçőyő‡Ř چžkď5%4ýŚm–7Ÿlqlio™ZłlG+ÔZÚz˛Íš­łmzyâň]íÔöĘö?uřuôw|ż"ĹąNťÎĺwW&ŽÜŰeÖĽďşą*|ŐöŐčjőę‰5kśŹyÝ­čţ˘ÇŻg°ç‡^yďkEk‡Öţ¸ŽlÝD_pßśőÄőÚő×7DmŘŐĎîoężť1măál {ŕűMśΠnßLÝlܤ[ţ˜¸™$™™üšhšŐ›B›Żœœ‰œ÷dŇž@žŽŸŸ‹Ÿú i ŘĄGĄś˘&˘–ŁŁvŁć¤V¤ÇĽ8ĽŠŚŚ‹Śý§n§ŕ¨R¨ÄŠ7ŠŠŞŞŤŤuŤéŹ\ŹĐ­D­¸Ž-ŽĄŻŻ‹° °u°ęą`ąÖ˛K˛Âł8łŽ´%´œľľŠśśyśđˇhˇŕ¸Y¸ŃšJšÂş;şľť.ť§ź!ź›˝˝žž„ž˙żzżőŔpŔěÁgÁăÂ_ÂŰĂXĂÔÄQÄÎĹKĹČĆFĆĂÇAÇżČ=ČźÉ:ÉšĘ8ʡË6ËśĚ5ĚľÍ5ÍľÎ6ÎśĎ7ϸĐ9ĐşŃ܊ÝݖŢޢß)߯ŕ6ŕ˝áDáĚâSâŰăcăëäsäüĺ„ć ć–ççŠč2čźéFéĐę[ęĺëpëűě†ííœî(î´ď@ďĚđXđĺńrń˙ňŒóó§ô4ôÂőPőŢömöű÷Šřř¨ů8ůÇúWúçűwüü˜ý)ýşţKţÜ˙m˙˙ ÷„óűendstream endobj 1 0 obj> endobj 2 0 obj>/Font>/ProcSet[/PDF/Text]/ExtGState>>> endobj 3 0 obj>streamH‰ŹWI“›HžëWäĽ'’‰†=ścş;ěn%ÇĘ}@’čAŔ Ş*EôŸˇą¨l—/S!ryůň-ß[ňż+_•j幞IáO%ĄďŚ‰ŠŇЍ#ľĆi˜¨ÎŽţ­ęŐŤ7ýFĺ˝ňéżĎaĺŸ[_űůźçFž„#ƒůüaőŻ‰úťŐŤÝÎ Ýa•şI¨jwžnőčoőÔ.ǟǕVÎîĎŐ:r}cÔ:pĂ Ü˝{+ëpɆ/ٸqBÇiŕ‰ŒqcoXƒř^ ×{ýsăŹýŔôŮ:ě~]˝Űąoś"ÁöÍopůŻ0úÔő6ę¤VÔýž*؜|YňźňŁ ˆ7ÎŤŐő&ĐH2˄"E1ŠDŇĽŐ˝×ę/ERĄSâŔ2‹›˜ –@đá×űćĘyŽŻőšŐ{Îô7ž/tHR7ţ#ÉB‡Éc¤ƒNęTÇYÇ ŽúXś ™ďn´uÖĆMtU֓ýgťűiäšp–Ëř)âë%š&’[Űnfa ś“m׉›ę¨˘+'v 0IőĄéßčó(’1ş~$ňÜŕ‚Œ$ˇ‚řÉ$Čč§YŹjەőqş7ŠÜtyoB†/ß;’üżŔEgÂpDĐéßŔs~|ěQúDŤżŠw7ýŕxzÜŹˆÖD/˘Ď¤ĆMÍŹe¤kSˉä[đ#ČÍúnĚ3;żq aƒXŒt=důMxLčBĐ`ž NÜŕeŠ„âÖô“Ç}?úJČ=ĄÎ0Œîp†!ąÁ_™M‚Iŕ&‹DzɏŹ4‘ÜĆŁ3˝XrPšżÔÖItéDpí`Ő¤ [ qюR„(ÔÂ(aŽ|9UL$K_=Ké˜!ňľö]˛ç4?ƒ%dIˇ—îĺ`Ą 1ćÖę}s,őF?ŃꝳĆtŽ”żÔš+ś–ĎëŞk'˜ý€T-§ĄWŸloť[¨7 ómŻÄŻ+9 †ČߍgaUŕÇľ^ř-Mç"#ćń$ |€TÂKŽĚdŃWů‰äj*K_ˆžtœ„MâŁĚMž‹ľĘęBA^w˘H^]sČ0Ĺh@¤VL,łËSáŤJšŐBĘלŹÚ37\N!”H˘˘:›ŃřüĹqŐŰ%ß^¨-_Ž†F1mžÔ€ĹmjâŞĘšŠ9S>ÔNHčOćń7lʋxÖ5ôÉŻ2ďď Ë­śďiú´éëĽ}ńRüžJŠÄ= #$Ű! @pşDŒÁ)ˇl'cuiikČţƒ&ĂáE$W`ěë˘W‰V&­w˙Î6?ą Ĺ?ĺŇuĎr°ô“ů#VjęĂîăhéoîKöG)7 Cт„öÁvj!•Ń…b€A1¨ŐÉźs ďëcĆź{Ő_ň‹”őˇŞĎŐۓęŇEh"!ŇJç-ŠPRę";-ëÍCÖ]1"耲WëňeŰ­t˘Ër1ťšÓ@™:Ź0˜Á&Eđ=ú-ÔGDH˘Ÿ{'DëdϘ†ď˛O-Ż6Î˘q`ŐĽˇ“GśďŸÖ$Ćz”ăôƒšŔůRŕBâŒ(Ć/;ž š)Á@„ä˘;uśCF+{‚)ŕ.ç{‹’Ś}Cť]ÁÇşţNńFÍňęÂ[rĂQ5{&íË᪘7‡!°Ćэv°b#Ŕ}Ş]‡Z.ĹS7J“ŠĚÎëç[rŘY@ŹhVb¤ůş,,}ĎĚż¤˝ĺţůĽëlMűƒăĂJľd$Đ;˜CŽQč,3šb3MĄý§ÁOÜÄÉő$~;2żfŸń@ąLM{áyĆ,ˆe¸#Ô#9öMôӄ‚ďd˝…EŚpH) Ax§¨ěc¨oŔśf‰řSö@č‹Ŕu–ž’CJxȘę :ÎOĚćČL+š\L29Ÿď˜ ŕ™Şřű Ě{WýBÜjf –.Ú.EȆ7Y0´MŠFřĂe>„SxĚČŚžÉ‹F_^lޚ1c…Bă÷˛|TmjłƒlŃż&śD(>ۂ‘…8XŒž­-㤘҅ M8§‹ š$I¤6ޝŞŕrÝâOÍE¤×猠˝’{’Ă7A¸˘ť{‰–°DȜšíŃéSŞ /Đ+ŽÝť˘%ú9 É FĐhHŠgmĆŰHXsís0¨ÓáÚrŞŒş‘:ŢŚüëSţZČéeë‰üH“iÔvŹMŰttySĎA@1w*á~÷向1ʁ>—9Ţ-/ĽĽ/"Ų~â^WŮžŚAӝyŁ’2ßđšě֍źš%Ż~J ßÜ6-íwÍ`ye¤ÄˆHć“\J! ŐgwëŢÝVżšöĽţĐ nŞ'ÇÁT˝ƒE­Žn-48P ú÷bY ŚüŐIË`pnĆŮp‚Úœ ôGÚSçĄr×g(ŽBŽZÄ%Đľ–nŻćĆĺ^?Rq/šcčqâd†ŚhŽŃĐ÷d7č˝ÚiŃn4’ó˘peąKĺîEÚUż”đ†h¸c*ԃƒq3žI.Ž"ĄŕŰŞJd¤.śVLÜ9˜řŹ˘v‚zZ^¨MőBG´ŚŘÁDPŠąŻ^čQŚ–§Ź@ČŠ,ÖŘĄ`e „GĚŚŽ˜XuMĺuĆWHřšŃ˛‚@ţE˙Lóˇďż8Xż ˝B×@6;‘Ÿ8ž´!+̃ŝ:XE1ÉsŠ!ĹOŠsCL/œ{p†|‚úÓ3˙ˇ‹ú";Jvú}/í3*‰) '@Ňč/űe>8ÍԔ'(›ŹřÖĄĺBť@ÇÍ $™)ľě‰”Sә 4Tfhđy+âFú§ĺfP€çt6­~/I%GC`EşGŠU!íçkNË ĺĆ'ÓUœ!ŻŘlŕ\‚4•ěÉ|j.>Š€#ćړ̵G:„ąŹ1x/‡ÁzETˆÔ‡ŕo …´Œú#Ç̉ąďPß/ĺ§ËßţźAßfžÔż†şH,XŘ÷A‹:jŔÖüŃö x‘źţ§UĹďGĂoŔę8”yV‹ôűđÔĽóűËŔ+řĚHč˝9ÝĎřťę8VNĺó­‰ô¨°ÜGdmşśĂVůĺ—IFíÁžť…žéZyŒmĹ,‡+çRśę#ˇŒŠŸüžÁgcĂďU0íÂVĐ3ÂBw¤/G~ 1l#~ÇĽňŽ‹41żă˘9ÝLϨĽR†Cu2c{‰/0¤.Ő5wÖ>űŕ´HÁEąŚQĎű-M žŤĂ…†uŽő2â ˝>ŕ‰ŢqFoQ‚5lnŒżŔő׏R!ŃSž+yŽÜž5˜Pž#5żG*VB!ŽńcÂɒ@š|€ Í"hąŽFó„Ôńą•Č$$¤Ę ˝éÄH~3Ă%fƄĹ˙^5=n"Aô>ż˘X˛ƒ ĆšeiEŠľ{Č^܌ŮĺK€=ăŸŞWҝŒöBÓTUQýŢŤóRJ›J“ĸ|}nWu-äÔt§r$Tň‰RĄÂ‡Fłg,§%d…ÚžĐv”¸˛tŠTŹƒĎśÔ°VĽ"öý~ż6ä|Úc7çˇz1:ĄŮG„J¤Îü85iœXˆóT˝doâ—2qű…CYŘóÜČ" ű@#”ű UÔzÂßa[â'‚V ăIî;ᄷvjîńEˆ€ţ}ŤĹB´ľA,ü łÎłŕCU/mÖŁ‚IŽ2ĽžťB.A’F,#]ĹĂuH§çĆńÁňܞĽÉ!ý?1ŒŇŚ¤¨§?Ą$ŘÎMKGa¨ŽIՀ.UęČ×u”ZŹÔvÉ)WoĽŘřÇů&öÝ'žD"‹DÄŤ|ĘŔÉ$VőznŽKžpźžzoˆźE[ş*fVW++Ňэž´ŞŘQ÷,rtäÓŹPôœÄ•ľˆőŚWómĎEzŚI°ŽJ0ŠxXú2Ń ‘%ĚŞ6n¸šhЙđ|J•Šc-ƒ˛x(‡HD§MUhńGXŕOd=féVŠřiÙRŁ‘ÚKqš-˔à 6â -'¨köÇáŒUQÇ°Bă‘2ë‹ÂÁs=Ă­ç^Đ'Š$$@c~–üH¤jĘĐyá‡)NܐH`YXăÝ ˇ‚ó‚'{đ`UKšĐՀ•š-śĚ X˛Á~EkR_a_lŇbîÁ`—†őҋ§]ýb*ěF +|ĘŞŃł6áÝ=R:2!nć3ƔŔšćş‘Qz˛+,ÓműĚdE‘VśTČnD+ásšÇha’n2źšČh#ćň 1Kłg1Ëp˄EŒÎ\Ýeů’K“?¸čoŸń ’ŕĹ­řjľu!ó?óŞ+ uŁŮRTź=]Cý›B~QH뎷xÄ÷HSˇsí¤\Š(""ŠšŠĄŚ×ᜰśg?ňfĺEˇˆĺ¤ŞˆuÎZ!ţlŔ¤ę'`íę3Ďšż}}u[a”œň( jyΛKWŰ}ړţ%ĆMŕ‘˜ MqçoW“~~÷ăîaˇqˇŐĽÁË0„f‚Ň9c0ň"‰pAcƒ%MşŠeŕ×Og'Ş˛#ĽđáĐţ:ŸTVŽ`÷éňˇ}n;Ű ÔóŤ"óýč>şsB%‚‰3ĆEďÁýčškY:ęŒh5äŒál˘ ŰôBz9‰űúö/J×,…kžSY„$Ënnv˘vĄ­›şjŔaÄuâף=OgǢyKLčŽv_OkËR‘đ}Ć ˛YKߍ/Ëq&OąźUň{:_-Ý ÔCďţŠ?„0n´â¤ŕÍ.>#ŒúĄŒI‚‡¸(_ăQx$1áT§‚HÖ9\6%2¤ý!KDǨe§†BÄűŠěí¤ŁËvÔUďmƒŘDžÍ_´Ő2œnĐŻ 9koendstream endobj 4 0 obj> endobj 5 0 obj> endobj 6 0 obj> endobj 7 0 obj> endobj 8 0 obj> endobj 9 0 obj> endobj 10 0 obj>stream sanna.hug http://www.surfacelogix.com/news/news_080129.htm endstream endobj 11 0 obj> endobj xref0 120000000000 65535 f0000013742 00000 n0000013867 00000 n0000013997 00000 n0000017810 00000 n0000018048 00000 n0000018204 00000 n0000018291 00000 n0000018366 00000 n0000019556 00000 n0000019613 00000 n0000023090 00000 ntrailer>startxref116%%EOF

  • When was Surface Logix founded?

    Surface Logix was founded in 1999.

  • Where is Surface Logix's headquarters?

    Surface Logix's headquarters is located at 50 Soldiers Field Place, Brighton.

  • What is Surface Logix's latest funding round?

    Surface Logix's latest funding round is Acquired.

  • How much did Surface Logix raise?

    Surface Logix raised a total of $114M.

  • Who are the investors of Surface Logix?

    Investors of Surface Logix include Nano Terra Inc., Venrock, ARCH Venture Partners, Intel Capital, HBM Partners and 12 more.

  • Who are Surface Logix's competitors?

    Competitors of Surface Logix include Evolva Holding, Concert Pharmaceuticals, Banyan Biomarkers, Stemina Biomarker Discovery, numares and 12 more.

You May Also Like

T
Total Pharmaceutical Care

Total Pharmaceutical Care, Inc. offers home healthcare and infusion therapy services

n
numares

numares, formerly LipoFIT Analytic, is a specialized developer and provider of analytic and diagnostic test systems based on nuclear magnetic resonance (NMR) spectroscopy and numares' proprietary Magnetic Group Signaling (MGS) technology. numares HEALTH develops and markets in-vitro diagnostic tests with the CE-marking and integrated test systems for high-throughput use in clinical diagnostics and life science research. The highly standardized tests provide valuable information on the disease status of patients in the indication areas of cardiovascular disease, nephrology and oncology. In addition, numares HEALTH provides its test systems to the pharmaceutical industry on a fee-for-service basis. They can be used for example to investigate the therapeutic effects of medication as part of clinical trials. Furthermore, the company supports customers with complex issues and clinical trials, drawing on its many years of expertise and experience in the area of NMR spectroscopy and metabolomics.

O
Oxagen

Oxagen is a biopharmaceutical company that develops small molecule drugs for inflammatory and respiratory diseases.

P
PhysioGenix

PhysioGenix offers pharmacogenetics and physiological genetics products and services

T
Tequesta Marine Biosciences

Tequesta Marine Biosciences is a specialty pharmaceutical firm that develops small molecule therepeutic drugs for inflammatory conditions.

Chiral Technologies Logo
Chiral Technologies

Welcome to CHIRAL TECHNOLOGIES, INC., a supplier of columns, bulk stationary phases and separation services for chromatographic enantioselective separations to pharmaceutical, biotechnology, and fine chemicals companies. As users explore the company's site users will find many ways in which having CHIRAL TECHNOLOGIES as their partner can help users in all aspects of chromatographic resolution.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.